Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAIT vs BST in Advanced Hepatocellular Carcinoma
NCT00524498Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Sep 2007
- Primary completion
- Jan 2010
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa in hepatocellular carcinoma (HCC), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Sep 2007; status: completed.
02
Drugs
interferon alfa
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00524498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524498.